DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.

We previously described PASD1 as a new cancer testis antigen in multiple myeloma (MM) that is retained post-therapy, suggesting the use of vaccination strategies to induce anti-PASD1 immunity in a setting of minimal residual disease. We have focused on DNA fusion gene vaccines, coupling fragment C d...

詳細記述

書誌詳細
主要な著者: Joseph-Pietras, D, Gao, Y, Zojer, N, Ait-Tahar, K, Banham, A, Pulford, K, Rice, J, Savelyeva, N, Sahota, S
フォーマット: Journal article
言語:English
出版事項: 2010

類似資料